Clin2
NCT07305220Possibly a fitNot yet recruiting

Safety of ultrasound-guided lung biopsy for ILD patients

Interstitial Lung Disease (ILD)

Part of Lungs & breathing clinical trials.

This trial checks how safe a lung biopsy (a small sample taken with a needle) is for people with interstitial lung disease, a condition that causes scarring in the lungs. The goal is to see if the biopsy can be done with fewer risks when guided by ultrasound.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
15 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with diffuse interstitial lung disease (ILD).
  • Doctors have decided a lung biopsy is needed after standard tests.
  • You are not on long-term oxygen therapy.
  • Your lung function is not severely reduced (FVC above 55% and DLCO above 40%).
  • You do not have a bleeding disorder, severe obesity (BMI >35), or a condition that makes biopsy unsafe.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07627594Not yet recruiting
Safety of bronchoscopy in interstitial lung disease patients

This study watches to see if a lung procedure called bronchoscopy is safe for people with interstitial lung disease (a condition where lung tissue becomes scarred or inflamed). Researchers will track how patients do during and after the procedure.

Paris
NCT07500818Recruiting
Robot vs. standard scope for lung biopsy in ILD

This study compares a robotic-assisted bronchoscope to a conventional one for performing a lung biopsy (cryobiopsy) in people with interstitial lung disease. The goal is to see which method is better at getting enough tissue for a diagnosis.

Lucerne, Canton of Lucerne
NCT07482917Recruiting
Streamlining the diagnosis of interstitial lung disease

This study is testing a new way to speed up the diagnosis of interstitial lung disease (a group of lung scarring conditions). If you have symptoms or scan findings that suggest ILD but haven't been fully diagnosed yet, this trial may help you get a faster, clearer answer.

Granollers, Barcelona
NCT06998706Recruiting· Phase 1
Testing patient's own lung stem cells for ILD

This study tests whether a patient's own lung stem cells can be used to repair damaged lungs in people with interstitial lung disease. It is an early-stage trial to see if the treatment is safe and may help improve breathing.

Qionghai, Hainan
NCT07615504Recruiting
Better diagnostic testing for interstitial lung disease

This research study tests new diagnostic methods to better identify and predict outcomes in interstitial lung disease (a group of lung conditions causing scarring and breathing problems). Researchers are looking for people with ILD or those exposed to pigeons, which can trigger a type of lung disease.

Blackpool
NCT07208201Not yet recruiting
Lung fluid study for interstitial lung disease diagnosis

This study uses a lung wash (bronchoalveolar lavage) to look at the types of immune cells in the lungs of people with certain lung scarring diseases called interstitial lung diseases (ILD). It may help doctors better understand different ILD types and guide treatment.

Hear when a new Interstitial Lung Disease (ILD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.